The article discusses need for improved analytics to detect and classify contaminants in cell and gene therapies (CGTs). Topics discussed include focus on next-generation sequencing (NGS) for contamination tracing; focus to develop novel rapid sterility tests for CGTs; and opportunity for new advances in technology to play a significant role in ensuring the safety of therapeutics.
Processing Request
No Comments.